-
Reckitt Benckiser Pharmaceuticals Inc. et al v. Watson Laboratories Inc. et al. DC CAFC
- 1:14-cv-01574
- D. Del.
- Judge: Richard G. Andrews
- Filed: 12/31/2014
- Closed: 10/01/2019
- Latest Docket Entry: 11/16/2020
- PACER
- Docket updated daily
2
Plaintiffs
2
Defendants
2
Accused
Products
2
Patents-in-Suit
1,736
Days in
Litigation
-
Reckitt Benckiser Pharmaceuticals Inc. et al v. Watson Laboratories Inc. et al. DC CAFC
- 1:14-cv-01574
- D. Del.
- Judge: Richard G. Andrews
- Filed: 12/31/2014
- Closed: 10/01/2019
- Latest Docket Entry: 11/16/2020
- PACER
- Docket updated daily
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
-
Infringement
Actavis Laboratories UT Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Buprenorphine hydrochloride and naloxone hydrochloride sublingual film | US 8,900,497 B2 |
24
|
No infringement
Entry 205
|
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Biotech and PharmaBuprenorphine hydrochloride and naloxone hydrochloride sublingual filmGeneric buprenorphine hydrochloride | US 8,900,497 B2 |
24
|
No infringement
Entry 205Entry 205 Entry 203 |
